666 related articles for article (PubMed ID: 15746665)
1. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
2. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
[TBL] [Abstract][Full Text] [Related]
4. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
Schiettecatte J; Russcher H; Anckaert E; Mees M; Leeser B; Tirelli AS; Fiedler GM; Luthe H; Denk B; Smitz J
Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
[TBL] [Abstract][Full Text] [Related]
5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
6. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
Kim YN; Lee DS; Jeong DH; Sung MS; Kim KT
Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927
[TBL] [Abstract][Full Text] [Related]
8. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
[TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
12. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
Sun SG; Shen N; Zheng YH; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
[TBL] [Abstract][Full Text] [Related]
14. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.
Masuyama H; Segawa T; Sumida Y; Masumoto A; Inoue S; Akahori Y; Hiramatsu Y
BJOG; 2010 Feb; 117(3):314-20. PubMed ID: 20015306
[TBL] [Abstract][Full Text] [Related]
15. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
17. Fractional excretion of angiogenic factors in women with severe preeclampsia.
Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417
[TBL] [Abstract][Full Text] [Related]
18. Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe preeclampsia.
Doherty A; Carvalho JC; Drewlo S; El-Khuffash A; Downey K; Dodds M; Kingdom J
J Obstet Gynaecol Can; 2014 Aug; 36(8):692-700. PubMed ID: 25222164
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.
Wang Y; Zhao S; Loyd S; Groome LJ
Am J Physiol Renal Physiol; 2012 May; 302(9):F1084-9. PubMed ID: 22301621
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.
Guseh SH; Feinberg BB; Dawood HY; Yamamoto HS; Fichorova RN; Burwick RM
Am J Reprod Immunol; 2015 May; 73(5):437-44. PubMed ID: 25521546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
